A citation-based method for searching scientific literature

Thomas T DeLeon, Daniel H Ahn, James M Bogenberger, Panos Z Anastasiadis, Mansi Arora, Ramesh K Ramanathan, Bashar A Aqel, George Vasmatzis, Mark J Truty, Rahmi Oklu, Tanios S Bekaii-Saab, Mitesh J Borad. Future Oncol 2018
Times Cited: 15







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic spectra of biliary tract cancer.
Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki, Tomoki Shirota, Asmaa Elzawahry, Mamoru Kato, Natsuko Hama, Fumie Hosoda, Tomoko Urushidate, Shoko Ohashi,[...]. Nat Genet 2015
466
26

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Juan Valle, Harpreet Wasan, Daniel H Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Tim Iveson, Sharon Hughes, Stephen P Pereira,[...]. N Engl J Med 2010
20

HER2/neu-directed therapy for biliary tract cancer.
Milind Javle, Chaitanya Churi, HyunSeon C Kang, Rachna Shroff, Filip Janku, Rakesh Surapaneni, Mingxin Zuo, Christian Barrera, Humaid Alshamsi, Sunil Krishnan,[...]. J Hematol Oncol 2015
120
20

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
20

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.
Rondell P Graham, Emily G Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A Sitailo, George Vasmatzis, Stephen J Murphy, Robert R McWilliams, Steven N Hart, Kevin C Halling,[...]. Hum Pathol 2014
135
13

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
D Yoshikawa, H Ojima, M Iwasaki, N Hiraoka, T Kosuge, S Kasai, S Hirohashi, T Shibata. Br J Cancer 2008
257
13

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.
Jacqueline Fontugne, Jérémy Augustin, Anaïs Pujals, Philippe Compagnon, Benoit Rousseau, Alain Luciani, Christophe Tournigand, Daniel Cherqui, Daniel Azoulay, Jean-Michel Pawlotsky,[...]. Oncotarget 2017
76
13

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.
Agrin Moeini, Daniela Sia, Nabeel Bardeesy, Vincenzo Mazzaferro, Josep M Llovet. Clin Cancer Res 2016
106
13

Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Yasuhito Arai, Yasushi Totoki, Fumie Hosoda, Tomoki Shirota, Natsuko Hama, Hiromi Nakamura, Hidenori Ojima, Koh Furuta, Kazuaki Shimada, Takuji Okusaka,[...]. Hepatology 2014
237
13

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Chaitanya R Churi, Rachna Shroff, Ying Wang, Asif Rashid, HyunSeon C Kang, Jacqueline Weatherly, Mingxin Zuo, Ralph Zinner, David Hong, Funda Meric-Bernstam,[...]. PLoS One 2014
225
13

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Milind Javle, Maeve Lowery, Rachna T Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J Borad, Ramesh K Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla,[...]. J Clin Oncol 2018
227
13

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
Mitesh J Borad, Mia D Champion, Jan B Egan, Winnie S Liang, Rafael Fonseca, Alan H Bryce, Ann E McCullough, Michael T Barrett, Katherine Hunt, Maitray D Patel,[...]. PLoS Genet 2014
201
13

Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
Kento Misumi, Akimasa Hayashi, Junji Shibahara, Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Masashi Fukayama. Histopathology 2017
23
13

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
13

Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.
Aarti Sharma, Kiran Lata Sharma, Annapurna Gupta, Alka Yadav, Ashok Kumar. World J Gastroenterol 2017
107
13

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
632
13

Cholangiocarcinoma - evolving concepts and therapeutic strategies.
Sumera Rizvi, Shahid A Khan, Christopher L Hallemeier, Robin K Kelley, Gregory J Gores. Nat Rev Clin Oncol 2018
386
13

Locoregional therapies in cholangiocarcinoma.
Peter L Labib, Brian R Davidson, Ricky A Sharma, Stephen P Pereira. Hepat Oncol 2017
15
13

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
13

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.
Apinya Jusakul, Ioana Cutcutache, Chern Han Yong, Jing Quan Lim, Mi Ni Huang, Nisha Padmanabhan, Vishwa Nellore, Sarinya Kongpetch, Alvin Wei Tian Ng, Ley Moy Ng,[...]. Cancer Discov 2017
265
13

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.
Shahid A Khan, Brian R Davidson, Robert D Goldin, Nigel Heaton, John Karani, Stephen P Pereira, William M C Rosenberg, Paul Tait, Simon D Taylor-Robinson, Andrew V Thillainayagam,[...]. Gut 2012
451
13

Worldwide esophageal cancer collaboration.
T W Rice, V W Rusch, C Apperson-Hansen, M S Allen, L-Q Chen, J G Hunter, K A Kesler, S Law, T E M R Lerut, C E Reed,[...]. Dis Esophagus 2009
249
6

Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
Marcello Migliore, Damiano Calvo, Alessandra Criscione, Cristina Viola, Giuseppe Privitera, Corrado Spatola, Hector Soto Parra, Stefano Palmucci, Nicola Ciancio, Rosario Caltabiano,[...]. Future Oncol 2015
21
6


Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Zheng Wang, Pei Yang, Gan You, Wei Zhang, Zhao-Shi Bao, Tao Jiang, Chuan-Bao Zhang. Future Oncol 2018
1
100


Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.
Michael Ried, Karla Lehle, Reiner Neu, Claudius Diez, Patrick Bednarski, Zsolt Sziklavari, Hans-Stefan Hofmann. Eur J Cardiothorac Surg 2015
18
6



Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
L Depypere, T Lerut, J Moons, W Coosemans, G Decker, H Van Veer, P De Leyn, P Nafteux. Dis Esophagus 2017
24
6

Is uniportal thoracoscopic surgery a feasible approach for advanced stages of non-small cell lung cancer?
Diego Gonzalez-Rivas, Eva Fieira, Maria Delgado, Lucía Mendez, Ricardo Fernandez, Mercedes de la Torre. J Thorac Dis 2014
75
6


Longitudinal and circumferential resection margin in adenocarcinoma of distal esophagus and cardia.
Marcello Migliore, Doris Rassl, Alessandra Criscione. Future Oncol 2014
7
14

One hundred years of lung cancer.
Stephen G Spiro, Gerard A Silvestri. Am J Respir Crit Care Med 2005
233
6

Ground glass opacities management in the lung cancer screening era.
Marcello Migliore, Mariaconcetta Fornito, Manuela Palazzolo, Alessandra Criscione, Mariapia Gangemi, Francesco Borrata, Paolo Vigneri, Marco Nardini, Joel Dunning. Ann Transl Med 2018
35
6


Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
Laurent Bedenne, Pierre Michel, Olivier Bouché, Chantal Milan, Christophe Mariette, Thierry Conroy, Denis Pezet, Bernard Roullet, Jean-François Seitz, Jean-Philippe Herr,[...]. J Clin Oncol 2007
760
6

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Scott C Flanders, Janet Kim, Samuel Wilson, Jeffrey Braziunas, Sheldon Greenfield, John Billimek, Stanislav Lechpammer, Daniel W Lin, Lawrence Karsh, David I Quinn,[...]. Future Oncol 2018
1
100

Techniques of pneumonectomy. Video-assisted thoracic surgery pneumonectomy.
G Roviaro, F Varoli, C Vergani, M Maciocco. Chest Surg Clin N Am 1999
11
9



Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
Hania Wehbe, Roger Henson, Fanyin Meng, Janna Mize-Berge, Tushar Patel. Cancer Res 2006
167
6

A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma.
D P S Sohal, K Mykulowycz, T Uehara, U R Teitelbaum, N Damjanov, B J Giantonio, M Carberry, P Wissel, M Jacobs-Small, P J O'Dwyer,[...]. Ann Oncol 2013
52
6

FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
Jean-Florian Guion-Dusserre, Veronique Lorgis, Julie Vincent, Leila Bengrine, Francois Ghiringhelli. World J Gastroenterol 2015
44
6

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.
M Penz, G V Kornek, M Raderer, H Ulrich-Pur, W Fiebiger, A Lenauer, D Depisch, G Krauss, B Schneeweiss, W Scheithauer. Ann Oncol 2001
158
6

Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
Marie Bréchon, Marie Dior, Johann Dréanic, Bertrand Brieau, Marie-Anne Guillaumot, Catherine Brezault, Olivier Mir, François Goldwasser, Romain Coriat. Invest New Drugs 2018
12
8

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Carolyn D Britten, Elizabeth Garrett-Mayer, Steven H Chin, Keisuke Shirai, Besim Ogretmen, Tricia A Bentz, Alan Brisendine, Kate Anderton, Susan L Cusack, Lynn W Maines,[...]. Clin Cancer Res 2017
68
6

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
Jae Yong Cho, Yong Han Paik, Yoon Soo Chang, Se Joon Lee, Dong-Ki Lee, Si Young Song, Jae Bock Chung, Mi-Suk Park, Jeong-Sik Yu, Dong-Sup Yoon. Cancer 2005
88
6

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
Xiwei Ding, Roongruedee Chaiteerakij, Catherine D Moser, Hassan Shaleh, Jeffrey Boakye, Gang Chen, Albert Ndzengue, Ying Li, Yanling Zhou, Shengbing Huang,[...]. Oncotarget 2016
30
6

Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.
Daniela Sia, Bojan Losic, Agrin Moeini, Laia Cabellos, Ke Hao, Kate Revill, Dennis Bonal, Oriana Miltiadous, Zhongyang Zhang, Yujin Hoshida,[...]. Nat Commun 2015
152
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.